Company intelligence
Lexitas Pharma Services
More than a CRO: Your Partner for Unmatched Expertise and Precision in Ophthalmology Research
About Lexitas Pharma Services
Lexitas is a clinical research organization dedicated exclusively to ophthalmology since 2011. With unmatched expertise and precision in ophthalmic research, we deliver tailored approaches, rigorous quality standards, and unwavering commitment to operational success. Our dedicated team of ophthalmic experts guides each study with deep scientific and clinical experience, offering customized solutions to meet your needs at every stage of development. We have extensive experience in posterior and anterior segments, as well as rare diseases. Service Offerings: -Regulatory strategy -Study design and protocol development -Endpoint evaluation and selection -Site selection, management and training -Clinical project management and monitoring -Medical monitoring -Data management & Biostatistics -Reading center -Medical Affairs & commercialization strategies
Verified activity
Signals from Lexitas Pharma Services
4 published signals
Presence & Recognition
Lexitas Pharma Services will attend the Ophthalmology Futures European Forum in London on Thursday, September 10, and the 44th Annual Congress of The European Society of Cataract and Refractive Surgeons on September 11-15.
Reported by Lexitas Pharma Services
Presence & Recognition
Lexitas Pharma Services supports sponsors with a commitment to scientific rigor, operational excellence, and patient-focused research.
Reported by Lexitas Pharma Services
Presence & Recognition
Lexitas Pharma Services Chief Medical Officer David J. Tanzer, MD will be in Los Angeles, CA for The Retina Society's 59th Annual Scientific Meeting from September 23-26.
Reported by Lexitas Pharma Services
Customers & Market
Lexitas Pharma Services closed screening on a Phase 3 Dry Eye Disease study last week.
Reported by Lexitas Pharma Services